Skip to menu Skip to content Skip to footer

Development of an advanced Hepatitis B nanovaccine for human use - Stage 1 (2015)

Experts

Professor Chengzhong Yu

Professor and NHMRC Leadership Fellow
Australian Institute for Bioengineering and Nanotechnology
Chengzhong Yu
Chengzhong Yu